NCT06948448
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06948448
Title A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Ono Pharmaceutical Co. Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | CAN

Facility Status City State Zip Country Details
Mayo Clinic Arizona RECRUITING Phoenix Arizona 85054 United States Details
USC Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
Mayo Clinic Florida RECRUITING Jacksonville Florida 32224 United States Details
The Ohio State University Comprehensive Cancer Center RECRUITING Columbus Ohio 43221 United States Details
Princess Margaret Cancer Centre- University Health Network RECRUITING Toronto Ontario M5G 2M9 Canada Details
CHU Bordeaux - Hôpital Haut-Lévêque RECRUITING Pessac Gironde France Details
Hôpital Européen Georges Pompidou RECRUITING Paris Paris France Details
Hôpital Saint-Antoine RECRUITING Paris Paris France Details
Kobe City Medical Center General Hospital RECRUITING Hyōgo Kobe-shi Japan Details
National Hospital Organization Osaka National Hospital RECRUITING Osaka Osaka-shi Japan Details
Osaka General Medical Center RECRUITING Osaka Osaka-shi Japan Details
Osaka International Cancer Institute RECRUITING Osaka Osaka-shi Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field